Anne L. Peters, MD, is currently a professor at the Keck School of Medicine of the University of Southern California and the Director of the USC Clinical Diabetes Programs. She runs diabetes centers in Beverly Hills and in underserved East Los Angeles and works with the LA County Department of Health Services on a county-wide diabetes program. Dr. Peters earned her undergraduate degree from Wesleyan University located in Middletown, Conn. and her medical degree from the Pritzker School of Medicine at the University of Chicago. She performed her internal medicine residency at Stanford University Medical Center and fellowship in endocrinology at Cedars-Sinai Medical Center. She was in charge of the clinical diabetes programs at Cedars and then at UCLA before moving to USC. Dr. Peters has been a principal investigator on multiple clinical trials focusing on diabetes and diabetes prevention. She established the Community Diabetes Initiatives Research Center in collaboration with Children's Hospital Los Angeles with funding from the Keck Foundation, the JDRF, ADA, Rose Hills Foundation, California Nutrition Network and Helmsley Trust. Dr. Peters is a Principal Investigator for the NIH Look AHEAD Study and the UCLA/USC NIH P50 program project "Family and Neighborhood Interventions to Reduce Heart Disease Risk in East L.A." She has been an invited speaker at many local, national and international medical conferences. Dr. Peters has authored two books on diabetes and over 100 articles appearing in peer-reviewed medical journals including JAMA, Annals of Internal Medicine, Archives of Internal Medicine, Diabetes Care and the American Journal of Medicine. She serves on the ABIM Endocrine Board and the Board of the ADA. Dr. Peters received the ADA Outstanding Physician Clinician Award in 2008 and the 2010 Bernardo Houssay Award from the National Minority Quality Forum for her work with the underserved. She was a member of the type 2 diabetes treatment working group and is an author of the "ADA/EASD Position Statement on the Management of Hyperglycemia in Type 2 Diabetes".